REGENERON PHARMACEUT

REGN
Delayed Quote. Delayed  - 10/26 04:00:00 pm
585.74USD +1.02%
Prev.579.8100
Open574.6600
High587.6200
Low574.6600
Volume533 451
Latest news
2d ago
4d ago
5d ago
5d ago
Chart REGENERON PHARMACEUTICALS
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBullish
Resistance608658644
Spread/Res.-3,7%-11%-9,1%
Spread/Supp.5,5%13%25%
Support555516470
Financials
Sales 2020 8 278 M - -
Net income 2020 2 973 M - -
Net cash 2020 5 675 M - -
P/E ratio 2020 21,5x
Yield 2020 -
Capitalization 61 638 M 61 638 M -
EV / Sales 2020 6,76x
EV / Sales 2021 5,25x
Nbr of Employees 8 142
Free-Float 83,3%
Company
Regeneron Pharmaceuticals specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Sales break down by activity as follows:
- sales of products (61.5%);
- supply of collaborative services (33.3%): working with Sanofi...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-11-05 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 671,83 $
Last Close Price 585,74 $
Spread / Highest target 36,6%
Spread / Average Target 14,7%
Spread / Lowest Target -14,6%